InBody : 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

1. Type of Financial Statements	Consolidated Financial Statements
2. Details of Changes in Sales or Profit/Loss (KRW)	Current Fiscal Year	Previous Fiscal Year	Amount Increased/ Decreased	Increase/ Decrease Rate (%)
- Sales(Limited to the amount of Revenue according to sales of goods and services provided)	137,836,961,994	107,122,053,678	30,714,908,316	28.7
- Operating Income	36,299,025,980	19,096,757,174	17,202,268,806	90.1
- Profit from continuing operation before corporate income tax	39,329,875,871	20,668,364,542	18,661,511,329	90.3
- Net Income	34,142,215,371	17,554,569,890	16,587,645,481	94.5
- Applicability of Large-scale Corporation	No
3. Financial Status (KRW)	Current Fiscal Year	Previous Fiscal Year
- Total Assets	203,875,182,997	166,150,336,180
- Total Liabilities	19,934,212,082	15,968,005,685
- Total Shareholders' Equity	183,940,970,915	150,182,330,495
- Capital Stock	6,841,891,000	6,841,891,000
4. Main Reasons for Changes in Sales or Profits/Losses	Product sales increase due to increases sales in overseas markets.
5. Date Of Board Of Directors Resolution(Decision Date)	2022-02-25
- Attendance of Outside Directors	Present(No.)	2
Absent(No.)	-
- Attendance of Auditors(members of Audit Committee)	Present
6. Other references concerning investment decisions	- The above results are consolidated financial statements based on K-IFRS. - The 2021 data provided in this document is for investor convenience only and has not been approved by the external auditor. The results above are currently under audited by the external auditor and might be subject to change.
※Relevant Disclosure	-
Note that this disclosure includes the un-audited information and some of the details may be changed according to the audit results